Drug Search Results
More Filters [+]

Diloxanide

Alternative Names: diloxanide
Latest Update: 2024-02-09
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | Egypt | Greece | India | Ireland | Pakistan | Philippines | Saudi Arabia | South Africa | Taiwan | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: University of Queensland
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Diloxanide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Inflammatory Bowel Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Nil

P3

Completed

Inflammatory Bowel Diseases

2014-02-20

Recent News Events